Paxlovid vs Ivermectin

Paxlovid

Ivermectin

Drug Class

Antiviral (Protease Inhibitor Combination)

Antiparasitic (Avermectin class)

Approved Uses

Treatment of mild-to-moderate COVID-19 in high-risk patients to prevent severe disease

Treatment of parasitic infections (e.g., onchocerciasis, strongyloidiasis)

Off-Label/Controversial Uses

None officially endorsed

Investigated but not recommended for COVID-19 treatment by WHO, FDA, and CDC

Mechanism of Action

Nirmatrelvir inhibits SARS-CoV-2 protease, preventing viral replication; ritonavir boosts nirmatrelvir levels by slowing its metabolism

Binds to parasite nerve and muscle cells, causing paralysis and death of the parasite

Formulation

Oral tablets (co-packaged)

Oral tablets, Topical formulations

Dosage

5-day regimen: Nirmatrelvir 300 mg + Ritonavir 100 mg twice daily

Based on parasitic infection; varies (e.g., 150–200 mcg/kg single dose for certain infections)

Common Side Effects

Altered taste, diarrhea, high blood pressure, muscle aches

Nausea, diarrhea, dizziness, rash

Severe Side Effects

Liver toxicity, drug interactions with CYP3A4 substrates, hypersensitivity

Neurological effects (in rare cases), liver injury

Efficacy for COVID-19

Proven effective in reducing hospitalization and death in high-risk patients

Not proven effective; major health agencies advise against use for COVID-19

Pregnancy Category

Limited data, not recommended unless benefit outweighs risk

Generally considered safe for parasitic infections during pregnancy but not for COVID-19

Drug Interactions

Significant (CYP3A4 inhibitors/inducers, anticoagulants, anticonvulsants, etc.)

Limited, but may interact with other drugs metabolized by P-glycoprotein

Approval Status

Emergency Use Authorization (EUA) for COVID-19

FDA-approved for parasitic infections but not for COVID-19

Special Considerations

Must start within 5 days of symptom onset for COVID-19; not suitable for severe renal or hepatic impairment

Overuse or misuse in COVID-19 has led to toxicity cases; not endorsed by health authorities for viral infections

Coupon

Coupon Code

IDMBLG30

Use This Coupon To Buy

Coupon Code

IDMBLG30

Use This Coupon To Buy

Frequently Asked Questions

What is the difference between Paxlovid and Ivermectin?

Paxlovid is an antiviral medication developed specifically to treat COVID-19. Ivermectin is an anti-parasitic drug that has been studied for COVID-19 but is not approved for this use. They work in completely different ways.

Is Paxlovid or Ivermectin more effective for COVID-19?

Paxlovid has shown strong results in clinical trials and is authorized to treat COVID-19. Ivermectin has not been proven effective in high-quality studies. Most medical experts recommend Paxlovid over Ivermectin for treating COVID-19.

Can you take Paxlovid and Ivermectin together?

There's no strong evidence supporting the combined use of Paxlovid and Ivermectin. Combining them could increase the risk of side effects. Always talk to your doctor before mixing any medications.

Which has more side effects: Paxlovid or Ivermectin?

Paxlovid may cause a metallic taste, diarrhea, or interactions with other drugs. Ivermectin side effects may include nausea and dizziness. However, using Ivermectin without proper approval may carry added risks.